📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Adimab

1.1 - Company Overview

Adimab Logo

Adimab

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an antibody discovery and optimization platform developing full-length human Immunoglobulin Gs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Adimab

VirTrial Logo

VirTrial

HQ: United States Website
  • Description: Provider of a telehealth platform and eClinical solutions for clinical trials, enabling virtual patient visits via secure video, audio, chat, and messaging on any device. Offerings include eConsent, telemedicine for remote assessments and data capture, a clinical data hub for real-time aggregation, eCOA, RTSM, and an integrated platform combining EDC, eCOA, eConsent, RTSM, and TeleVisits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VirTrial company profile →
Evozyne Logo

Evozyne

HQ: United States Website
  • Description: Provider of generative AI-driven protein design and engineering solutions for therapeutic discovery and drug development, including ProT-VAE (co-developed with NVIDIA) to design therapeutic proteins, protein engineering for rare diseases (in partnership with Takeda), evolutionary deep learning to create novel proteins, and computational chemistry to optimize protein stability and function.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Evozyne company profile →
Parabricks Logo

Parabricks

HQ: United States Website
  • Description: Provider of high-performance genomic analysis that can analyze a whole human genome in under an hour, compared to days, using state-of-the-art GPU acceleration and machine learning. Enables users to significantly increase throughput and supports personalized treatment based on genomic variations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Parabricks company profile →
BEKHealth Logo

BEKHealth

HQ: United States Website
  • Description: Provider of AI-powered chart abstraction and patient-matching solutions that analyze structured and unstructured EMR data to optimize clinical trial enrollment. Services include an automated ETL pipeline via proprietary EMR adapters, an AI data platform to standardize and translate medical data, patient matching, study rescue, and sponsor–site matching.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BEKHealth company profile →
Cisiv Logo

Cisiv

HQ: United Kingdom Website
  • Description: Provider of real-world data technology for pharmaceutical companies, including Baseline Plus for late-phase research with customizable workflows; a 21 CFR Part 11-compliant eConsent module integrated with Baseline Plus; patient apps for PROs, COAs, and eDiaries; electronic tools for observational studies; support for post-approval safety studies (PASS); and systems for retrospective chart reviews.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cisiv company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Adimab

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Adimab

2.2 - Growth funds investing in similar companies to Adimab

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Adimab

4.2 - Public trading comparable groups for Adimab

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Adimab

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Adimab

What does Adimab do?

Adimab is a provider of an antibody discovery and optimization platform developing full-length human Immunoglobulin Gs.

Who are Adimab's competitors?

Adimab's competitors and similar companies include VirTrial, Evozyne, Parabricks, BEKHealth, and Cisiv.

Where is Adimab headquartered?

Adimab is headquartered in United States.

How many employees does Adimab have?

Adimab has 1,000 employees 🔒.

When was Adimab founded?

Adimab was founded in 2010 🔒.

What sector and industry vertical is Adimab in?

Adimab is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Adimab

Who are the top strategic acquirers in Adimab's sector and industry

Top strategic M&A buyers and acquirers in Adimab's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Adimab?

Top strategic M&A buyers groups and sectors for Adimab include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Adimab's sector and industry vertical

Which are the top PE firms investing in Adimab's sector and industry vertical?

Top PE firms investing in Adimab's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Adimab's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Adimab's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Adimab's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Adimab include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Adimab's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Adimab?

The key public trading comparables and valuation benchmarks for Adimab include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Adimab for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Adimab with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Adimab's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Adimab with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Adimab's' sector and industry vertical?

Access recent funding rounds and capital raises in Adimab's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Adimab